Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Cellectar Biosciences	Regulus Therapeutics	Genprex	Zosano Pharma	Provectus Biopharmaceuticals
Symbol	NASDAQ:CLRB	NASDAQ:RGLS	NASDAQ:GNPX	NASDAQ:ZSAN	OTCMKTS:PVCT
Price Information
Current Price	$2.16	$0.68	$3.90	$0.62	$0.06
52 Week Range	Buy	Hold	Buy	Buy	N/A
Analyst Ratings
Consensus Recommendation	Buy	Hold	Buy	Buy	N/A
Consensus Price Target	$6.33	$1.50	$5.00	$10.00	N/A
% Upside from Price Target	193.21% upside	119.30% upside	28.21% upside	1,500.26% upside	N/A
Trade Information
Market Cap	$21.70 million	$15.35 million	$204.65 million	$22.61 million	$23.21 million
Beta	1.35	1.71	-0.42	2.61	0.81
Average Volume	286,552	108,034	13,580,398	3,959,490	290,374
Sales & Book Value
Annual Revenue	N/A	$70,000.00	N/A	N/A	N/A
Price / Sales	N/A	205.40	N/A	N/A	N/A
Cashflow	N/A	N/A	N/A	N/A	N/A
Price / Cash	N/A	N/A	N/A	N/A	N/A
Book Value	$2.26 per share	($0.67) per share	$0.59 per share	$1.56 per share	($0.05) per share
Price / Book	N/A	-1.02	N/A	N/A	N/A
Profitability
Net Income	$-13,240,000.00	$-48,710,000.00	$-12,370,000.00	$-35,360,000.00	$-8,150,000.00
EPS	($4.66)	($5.59)	($0.90)	($3.74)	N/A
Trailing P/E Ratio	N/A	N/A	N/A	N/A	N/A
Forward P/E Ratio	N/A	N/A	∞	∞	∞
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	N/A	-325.85%	N/A	N/A	N/A
Return on Equity (ROE)	-130.08%	N/A	-186.71%	-268.73%	N/A
Return on Assets (ROA)	-93.21%	-93.83%	-172.26%	-100.93%	-303.35%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	0.04%	N/A	N/A	0.60%	N/A
Current Ratio	4.95%	0.93%	6.72%	0.51%	0.38%
Quick Ratio	4.95%	0.93%	5.23%	0.51%	0.38%
Ownership Information
Institutional Ownership Percentage	13.82%	34.07%	2.52%	37.89%	0.03%
Insider Ownership Percentage	4.26%	10.70%	29.01%	14.00%	4.50%
Miscellaneous
Employees	7	24	N/A	53	2
Shares Outstanding	9.40 million	21.02 million	32.85 million	30.54 million	390.69 million
Next Earnings Date	5/4/2020 (Estimated)	3/16/2020 (Estimated)	4/6/2020 (Estimated)	3/12/2020 (Estimated)	3/5/2020 (Estimated)
Optionable	Not Optionable	Optionable	Not Optionable	Not Optionable	Not Optionable

Comparison Ideas:

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

Start Your Free Trial Today

Market Data and Calendars

Investing Education and Resources